SR9009 10 (Stenabolic)

ACTIVE HALF-LIFE 4-6 hours
CLASSIFICATION PPAR alpha modifier
DOSAGE 20-30 mg/day
MANUFACTURER Deus Medical
LAB TEST See Document
WAREHOUSE EU Warehouse 2
SUBSTANCE Stenabolic

Introducing Stenabolic (SR 9009), an innovative PPAR alpha modifier developed by the renowned Professor Thomas Burris at the Scripps Research Institute. This versatile compound, often marketed as both a SARM and a cutting-edge research chemical, is gaining traction for its remarkable ability to enhance exercise performance and metabolic health. Similar to Cardarine (GW-501516), Stenabolic functions as an agonist of Rev-ErbA, making it a powerful ally in your fitness journey. Research published in "National Medicine" highlights its potential to boost exercise capacity in mice by increasing mitochondrial production in skeletal muscle, earning it the nickname ?exercise in a bottle.?

Stenabolic effectively modifies skeletal muscle mitochondria, significantly ramping up metabolic activity. While it draws comparisons to DNP, SR 9009 is considered a safer option that promotes endurance rather than detracting from it. Unlike DNP, which can hinder performance, SR 9009 mimics the benefits of aerobic exercise, enhancing endurance without the need for rigorous training.

This remarkable compound binds to the Rev-erbA protein, which is crucial for regulating fat and sugar metabolism in the liver, controlling fat cell production, and modulating the body?s inflammatory responses. This unique interaction means that even if you lead a sedentary lifestyle, Stenabolic can help you achieve your fitness goals by promoting the use of energy from food rather than storing it as fat?effectively targeting and burning existing fat stores.

Results

With Stenabolic (SR 9009), users can expect to become leaner and experience improved cardiovascular endurance, allowing for longer distances without rapid fatigue. Enhanced VO2 max translates to superior endurance performance, making it an asset for athletes and fitness enthusiasts alike. Furthermore, non-athletes can benefit from Stenabolic?s potential to combat obesity, metabolic syndrome, and type 2 diabetes.

Mouse Studies

In studies involving mice with low muscle mass and sluggish metabolic rates?akin to out-of-shape humans?results showed significant improvements in muscle mass and metabolic activity following Stenabolic administration, even without exercise. When given the opportunity to run, these mice managed to cover 50% more distance without fatigue, showcasing the compound's impressive capabilities.

Side Effects

Unlike traditional fat burners, thyroid enhancers, or appetite suppressants such as clenbuterol, T3, or specific stimulants, SR 9009 does not lead to crashes or fatigue. However, as Stenabolic is relatively new and has limited use among human athletes, further research is essential to uncover any potential side effects.

Dosages

The recommended dosage for Stenabolic is between 20-30 milligrams (mg) per day, with the flexibility to adjust by 10 mg based on individual needs. Typical cycles range from 6 to 8 weeks, and stacking SR 9009 with Cardarine (GW-501516) is recommended for amplified endurance benefits. Although Stenabolic has a shorter half-life compared to Cardarine, requiring 3-4 doses per day, some users have reported success with just 2-3 daily doses.